Wall Street Is Bullish on Nektar Stock despite Stock Price Slump
Does Nektar's Stock Price Correction Signal a Good Opportunity? Nektar Therapeutics (NKTR) is a development-stage biotechnology company that has a drug pipeline focused on the treatment of cancer, autoimmune diseases, and chronic pain. The company has entered a number of key collaborations recently to advance its drug pipeline.